ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Baltimore, MD, USA:

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions invol...

Active, not recruiting
Pancreatic Cancer
Drug: FOLFIRINOX
Radiation: SBRT

Phase 2

Mass General Brigham
Mass General Brigham

Baltimore, Maryland, United States and 9 other locations

Phase 2 study to evaluate the clinical activity of INCMGA00012 in patients with Unresectable or metastatic Adenosquamous Pancreatic or Ampul....

Enrolling
Pancreatic Cancer Non-resectable
Pancreatic Cancer Metastatic
Drug: INCMGA00012 (PD-1 antibody)

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

and/or radiation, as well as patients with metastatic colorectal cancer who have exposure to 2 or more lines of chemotherapy, to evaluate sa...

Enrolling
Pancreatic Cancer
Colorectal Cancer
Drug: Nivolumab
Drug: Ipilimumab

Phase 1

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

The study is a first-in-human, Phase I study to assess the safety of ProAgio in participants with advanced solid tumor malignancies includin ...

Enrolling
Solid Tumor Malignancies
Advanced Pancreatic Cancer
Drug: ProAgio Dose Levels (DL) 1,2,3
Drug: ProAgio Dose Levels (DL) 4,5,6

Phase 1

ProDa BioTech

Bethesda, Maryland, United States

or metastatic mismatch repair-proficient (MMR-p) colorectal cancer (mCRC) or unresectable or metastatic MMR-p pancreatic ductal ade...

Enrolling
Pancreatic Cancer
Colorectal Cancer
Drug: KRAS Vaccine with Poly-ICLC adjuvant
Drug: Botensilimab

Phase 1

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer...

Active, not recruiting
Pancreatic Adenocarcinoma
Metastatic
Genetic: VCN-01
Drug: Gemcitabine

Phase 2

Theriva Biologics

Fairfax, Virginia, United States and 16 other locations

A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...

Active, not recruiting
Pancreatic Cancer
Drug: Ramucirumab
Other: Placebo

Phase 2

Walid Shaib, MD

Gettysburg, Pennsylvania, United States and 7 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Fairfax, Virginia, United States and 22 other locations

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: Gemcitabine
Drug: AMG 193

Phase 1

Amgen
Amgen

Fairfax, Virginia, United States and 44 other locations

low dose chemotherapy with gemcitabine, nab-paclitaxel, capecitabine, cisplatin, and irinotecan (GAX-CI) in patients with untreated metastatic pancreatic...

Enrolling
Metastatic Pancreatic Cancer
Drug: Pembrolizumab
Drug: Gemcitabine

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems